Tuesday July 22, 8:48 am ET FDA Meeting to Discuss Development Plan Completed Successfully DUBLIN, Ireland, July 22 /PRNewswire-FirstCall/ -- News ) today announced that the Company recently met with officials at the U.S. Food...
With this airfare-only deal, plan your own trip to one of these Asian gems Traditional and modern, this visual tour shows off the many sides of Bangkok. U.S. citizens will need a valid passport, but no visas are required for...
Posted on: Thursday, 17 July 2008, 06:00 CDT Research and Markets (http://www.researchandmarkets.com/research/8bcf80/dyslipidemia_oppo) has announced the addition of the "Dyslipidemia: Opportunities in Cardiovascular Risk...
DUBLIN, July 8 /PRNewswire-FirstCall/ -- Amarin Corporation plc (NASDAQ: AMRN - News ) announced today it has sent to its shareholders a Notice of the Annual General Meeting of the Company, which will be held on July 31, 2008....
IT IS now possible for Malaysians to have solar-powered homes. Three housing developers are offering high-end homes equipped with photovoltaic (PV) systems, in the Klang Valley. In its latest phase at Setia Eco Park in Shah...
Rick Stewart, the former chief executive at clinical research firm Amarin who left the company at the beginning of the year, received a total package worth €1.5m in 2007, according to the company's annual report. The 2007...
Research that has yielded success in controlling certain errors in gene expression as a safer and more effective alternative to conventional drugs has won for Prof. Hermona Soreq, dean of the Faculty of Science at the Hebrew...
Appointment Announced during Annual General Meeting of Shareholders MISSISSAUGA, ON, June 27 /CNW/ - MedX Health Corp. (TSXV: MDX) announced the promotion of Steven T. Guillen to president and chief executive officer of MedX...
Attention Business Editors Appointment Announced during Annual General Meeting of Shareholders MISSISSAUGA, ON, June 27 /CNW/ - MedX Health Corp. (TSXV: MDX) announced the promotion of Steven T. Guillen to president and chief...
ROSEVILLE, Calif.----Dutton Associates continues coverage of Amarin Corporation plc , maintaining its rating at Speculative Buy and its $7.00 price target. The 11-page report by Dutton senior analyst Stephen Handley is...